GENMAB AS SP.ADR/1/10DK 1 (GE91) — Free Cash Flow Generation Index

Latest as of December 2025: 0.96x

GENMAB AS SP.ADR/1/10DK 1 (GE91) has a Free Cash Flow Generation Index of 0.96x as of December 2025. Free cash flow of €288.00 Million represents 1% of operating cash flow (€301.00 Million). See working capital position of GENMAB AS SP.ADR/1/10DK 1 to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.96x
Free Cash Flow / Operating CF

Free Cash Flow

€288.00 Million
EUR

Operating Cash Flow

€301.00 Million
EUR

Capital Expenditures

€13.00 Million
EUR

GENMAB AS SP.ADR/1/10DK 1 Free Cash Flow Generation Index (2021–2025)

Historical FCF Generation Index trend for GENMAB AS SP.ADR/1/10DK 1 across 5 annual periods. Explore how well can GENMAB AS SP.ADR/1/10DK 1 service its debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for GENMAB AS SP.ADR/1/10DK 1 (2021–2025)

Year-by-year Free Cash Flow Generation Index for GENMAB AS SP.ADR/1/10DK 1. For the full company profile including market capitalisation, see market cap of GENMAB AS SP.ADR/1/10DK 1.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2025 0.95x €1.13 Billion €1.19 Billion €55.00 Million ▼ -0.8%
2024 0.96x €1.04 Billion €1.08 Billion €42.41 Million ▲ +1.2%
2023 0.95x €1.04 Billion €1.10 Billion €55.83 Million ▲ +3.3%
2022 0.92x €517.42 Million €563.05 Million €45.63 Million ▲ +3.6%
2021 0.89x €300.82 Million €339.18 Million €38.36 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).